通过创新的活性安慰剂来解决经典迷幻研究中的失明问题
Jacob S Aday1, Otto Simonsson2, Emmanuelle A D Schindler3,4
1Department of Anesthesiology, University of Michigan, Ann Arbor, MI, United States.
The international journal of neuropsychopharmacology
|April 4, 2025
概括
经典的迷幻药在神经精神疾病中显示出治疗潜力. 开发更好的活性安慰剂对于强大的临床试验至关重要,以确保这些有前途的治疗方法的可靠结果.
科学领域:
- 心理药理学 心理药理学
- 临床神经科学 临床神经科学
背景情况:
- 经典的迷幻药在治疗神经精神疾病方面表现有前途.
- 目前在迷幻药试验中使用的安慰剂对照药往往具有弱弱的盲目完整性.
- 这损害了观察到的治疗效果的解释性.
研究的目的:
- 在经典的迷幻研究中批评现有的安慰剂条件.
- 建立有效活性安慰剂的标准.
- 确定未来研究的潜在活性安慰剂候选人.
主要方法:
- 关于在迷幻药试验中使用安慰剂的文献.
- 理想的活性安慰剂的定义特征:精神活性/生理效应,发病/持续时间,安全性和缺乏治疗作用.
- 选药理学药剂作为潜在的活性安慰剂.
主要成果:
- 在迷幻研究中确定了当前安慰剂策略的局限性.
- 提出了一个选择适当活性安慰剂的框架.
- 突出了几种药理学药物,这些药物有可能作为各种迷幻药物管理协议的活性安慰剂.
结论:
- 严格选择活性安慰剂对于准确评估迷幻药疗效至关重要.
- 未来的研究必须采用深思熟虑的安慰剂选择和盲目的策略.
- 改进的失明是必要的,以验证经典的迷幻药作为治疗.
相关概念视频
Blinding
2.3K
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
2.3K
Blind Procedures
10.6K
Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which...
10.6K
The Placebo Effect
6.1K
The placebo effect occurs when people's expectations or beliefs influence or determine their experience in a given situation. In other words, simply expecting something to happen can actually make it happen.
6.1K
CNS Stimulants: Psychedelic Agents
106
Hallucinogens, also known as psychedelic drugs, are a class of substances known for their ability to alter perception, cognition, and emotions. Despite their profound effects on the mind, these drugs are non-addictive, setting them apart from many other abused substances. The mechanism of action of these drugs lies in their impact on the 5-HT2A receptor in the brain. Upon activation, this receptor couples to Gq-type G proteins, triggering a cascade that releases intracellular calcium. This...
106
Hallucinogens and Psychedelics
146
Hallucinogens are psychoactive substances that profoundly alter perceptual experiences, generating unreal visual and sensory images. Often referred to as psychedelic drugs — a term derived from the Greek words "psyche" (mind) and "delos" (revealing) — these substances include marijuana and lysergic acid diethylamide (LSD), among others. These drugs vary in intensity and effects.
Marijuana, derived from the dried leaves and flowers of the hemp plant, contains...
Marijuana, derived from the dried leaves and flowers of the hemp plant, contains...
146
Altered States of Awareness
127
Altered states of consciousness represent significant deviations from one's normal mental state. These deviations can range from subtle changes in awareness to profound transformations in perception, thought processes, and sensory experiences. Altered states of consciousness can be triggered by various factors, including drug use, meditation, hypnosis, illness, or even intense fatigue.
The ingestion of substances like stimulants or hallucinogens leads to chemical alterations in the brain...
The ingestion of substances like stimulants or hallucinogens leads to chemical alterations in the brain...
127


